Dinuclear copper complexes of organic claw: Potent inhibition of protein tyrosine phosphatases

详细信息    查看全文

• 作者：Ling Ma^a ; Liping Lu^a ; ^{luliping@sxu.edu.cn"" rel=""nofollow} ; Miaoli Zhu^a ; ^c ; ^{miaoli@sxu.edu.cn"" rel=""nofollow} ; Qingming Wang^a ; Fei Gao^a ; Caixia Yuan^a ; Yanbo Wu^a ; Shu Xing^b ; Xueqi Fu^b ; ^{fxq@jlu.edu.cn"" rel=""nofollow} ; Yuhua Mei^c ; Xiaoli Gao^d
• 关键词：Dinuclear copper complexes ; PTPs ; Inhibitor ; Selectivity
• 刊名：Journal of Inorganic Biochemistry
• 出版年：2011
• 出版时间：September 2011
• 年：2011
• 卷：105
• 期：9
• 页码：1138-1147
• 全文大小：1164 K

文摘

Three dinuclear copper complexes of organic claw ligands (2,2′,2″,2-(5-R-2-hydroxy-1,3-phenylene)bis(methylene)bis(azanetriyl)tetraacetic acid, R = methyl (H₅L1), chloro (H₅L2) and bromo (H₅L3)): [Cu₂NaL1(H₂O)₂] (1), [Cu₂HL2(H₂O)₂] (2), [Cu₂NaL3(H₂O)₂] (3), have been synthesized and characterized by elemental analyses, infrared spectra, thermo-gravimetric analyses, X-ray diffraction analysis, electrospray ionization mass spectra, pH-potentiometric titration, molar conductivity. Their inhibitory effects against human protein tyrosine phosphatase 1B (PTP1B), T cell protein tyrosine phosphatase (TCPTP), Megakaryocyte protein tyrosinephosphatase 2 (PTP-MEG2), srchomology phosphatase 1 (SHP-1) and srchomology phosphatase 2 (SHP-2) are evaluated in vitro. The three copper complexes exhibit potent and almost same inhibition against PTP1B and SHP-1 with IC₅₀ values ranging from 0.15 to 0.31 μM, about 2-fold stronger inhibition than against PTP-MEG2, 10-fold stronger inhibition than against TCPTP, but almost no inhibition against SHP-2. Kinetic analysis indicates that they are reversible competitive inhibitors of PTP1B. Molecular docking analyses confirm the inhibition model. Fluorescence titration studies suggest that the complexes bond to PTP1B with the formation of a 1:1 complex. The results demonstrate that copper complexes that are potent PTPs inhibitors but have different inhibitory effects over different PTPs, may be explored as new practical inhibitors towards individual PTP with some specificity.